Concepedia

Smriti Iyengar

SI

Statistics

Publications

55

Citations

5.6K

H-Index

29

Active since

1974

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

McLean Hospital

Smriti Iyengar is an author at Eli Lilly (United States) specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1974–2023

55

Publications

55

Duloxetine vs. placebo in patients with painful diabetic neuropathy

D. Goldstein, Yili Lu, Michael J. Detke et al. · Pain · 2005 · 847 citations

, , +17

A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

Lesley M. Arnold, Yili Lu, Leslie J. Crofford et al. · Arthritis & Rheumatism · 2004 · 637 citations

, , +16

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Joel Raskin, Yili Pritchett, Fujun Wang et al. · Pain Medicine · 2005 · 530 citations · Full text

, , +17

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Lesley M. Arnold, A. Rosen, Yili Pritchett et al. · Pain · 2005 · 473 citations

, , +17

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Amy S. Chappell, Melissa J. Ossanna, Hong Liu‐Seifert et al. · Pain · 2009 · 300 citations

, , +17

1–5 of 55